Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -40.27% is 518% below its 5-year average of -6.52%, near the high end of its 5-year range (-2309.57%–14.72%).
93.00% above its 12-month average of -574.99%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -309.90%.
EBITDA MARGIN
-40.27%
EBITDA MARGIN AVG TTM
-574.99%
EBITDA MARGIN AVG 3Y
-38.97%
EBITDA MARGIN AVG 5Y
-6.52%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+93.00%
CURRENT VS 3Y AVG
-3.35%
CURRENT VS 5Y AVG
-517.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BioNexus Gene Lab Corp.
Market Cap
$2.92M
EBITDA Margin
-40.27%
TTM Avg
-574.99%
3Y Avg
-38.97%
5Y Avg
-6.52%
Market Cap
$3.10M
EBITDA Margin
-105.34%
TTM Avg
-42.86%
3Y Avg
-8.83%
5Y Avg
21.58%
Market Cap
$2.75M
EBITDA Margin
-161.83%
TTM Avg
-364.15%
3Y Avg
-746.27%
5Y Avg
-739.07%
Market Cap
$2.73M
EBITDA Margin
4.51%
TTM Avg
6.50%
3Y Avg
5.75%
5Y Avg
5.47%
Market Cap
$2.73M
EBITDA Margin
-300.55%
TTM Avg
-244.13%
3Y Avg
-139.96%
5Y Avg
-80.29%
Market Cap
$3.17M
EBITDA Margin
-125.33%
TTM Avg
-77.72%
3Y Avg
-55.85%
5Y Avg
-61.37%
Market Cap
$3.31M
EBITDA Margin
-60.70%
TTM Avg
-63.88%
3Y Avg
-65.94%
5Y Avg
-81.03%
Market Cap
$3.38M
EBITDA Margin
-18.06%
TTM Avg
-10.77%
3Y Avg
-9.65%
5Y Avg
-8.67%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNexus Gene Lab Corp. (BGLC) | $2.92M | -40.27% | -574.99% | -38.97% | -6.52% |
| PTL Limited (PTLE)vs › | $3.07M | -0.57% | -0.59% | 0.09% | 0.09% |
| Intelligent Group Limited (INTJ)vs › | $3.10M | -105.34% | -42.86% | -8.83% | 21.58% |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.75M | -161.83% | -364.15% | -746.27% | -739.07% |
| Globavend Holdings Limited (GVH)vs › | $2.73M | 4.51% | 6.50% | 5.75% | 5.47% |
| Top KingWin Ltd. Class A (DPU)vs › | $2.73M | -300.55% | -244.13% | -139.96% | -80.29% |
| Polar Power, Inc. (POLA)vs › | $3.17M | -125.33% | -77.72% | -55.85% | -61.37% |
| Iveda Solutions, Inc. (IVDA)vs › | $3.31M | -60.70% | -63.88% | -65.94% | -81.03% |
| Addentax Group Corp. (ATXG)vs › | $3.38M | -18.06% | -10.77% | -9.65% | -8.67% |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.31M | -43.04% | -21.27% | -7.87% | -4.56% |
Gross Margin
11.6%
EBITDA Margin
-40.3%
Operating Margin
-42.5%
Net Margin
-82.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -309.90% |
| 2026-03-31 | -2309.57% |
| 2025-12-31 | -204.40% |
| 2025-09-30 | -25.91% |
| 2025-06-30 | -25.20% |
| 2025-03-31 | -27.06% |
| 2024-12-31 | -14.79% |
| 2024-09-30 | -48.99% |
| 2024-06-30 | 14.72% |
| 2024-03-31 | -2.08% |
| 2023-12-31 | 12.60% |
| 2023-09-30 | -97.87% |
| 2023-06-30 | -9.65% |
| 2023-03-31 | -1.08% |
| 2022-12-31 | -3.40% |
| 2022-09-30 | -1.53% |
| 2022-06-30 | -4.47% |
| 2022-03-31 | 2.03% |
| 2021-12-31 | 7.01% |
| 2021-09-30 | 11.17% |
| 2021-06-30 | 5.82% |
| 2021-03-31 | 10.35% |
| 2020-12-31 | 13.29% |
| 2020-09-30 | 8.11% |
| 2020-06-30 | -1.97% |
| 2020-03-31 | 35.40% |
| 2019-12-31 | -161.60% |
| 2019-09-30 | -164.63% |
| 2019-06-30 | -271.78% |
| 2019-03-31 | -176.73% |
| 2018-12-31 | -656.66% |
| 2018-09-30 | -49.30% |
| 2018-06-30 | -26.23% |
| 2017-12-31 | -78.93% |
